HAM-A

Advertisement

cGxPJobs Banner

Otsuka Reports Phase 3b SIMTRIYO Data in ADHD and Anxiety

PRINCETON, N.J. and TOKYO, Japan — September 18, 2026 Otsuka Pharmaceutical presented new Phase 3b results for SIMTRIYO® (centanafadine)...

By cGxPwire Editor
September 23, 2026

Read More

Advertisement

cGxPJobs

Directory